Definity and Magnesium - low - a phase IV clinical study of FDA data
We study 4,016 people who take Definity or have Magnesium - low. No report of Magnesium - low is found in people who take Definity.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No report is found.
What is Definity?
Definity has active ingredients of perflutren. eHealthMe is studying from 3,851 Definity users for its effectiveness, alternative drugs and more.
What is Magnesium - Low?
Magnesium - low: no further information found.
Do you take Definity and have Magnesium - low?Check whether Magnesium - low is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Magnesium - low and when was it recovered:
Expand to all the drugs that have ingredients of perflutren:
Alternative drugs to, pros and cons of Definity:
- Definity (3,851 reports)
Magnesium - low treatments and more:
- Magnesium - low (165 reports)
COVID vaccines that are related to Magnesium - low:
- Magnesium - low in Moderna COVID Vaccine
- Magnesium - low in Pfizer BioNTech Covid Vaccine
- Magnesium - low in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Magnesium - low:
All the conditions that are associated with Magnesium - low:
How the study uses the data?
The study uses data from the FDA. It is based on perflutren (the active ingredients of Definity) and Definity (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Chromium Picolinate vs. Adderall 20 - 6 seconds ago
- Solifenacin Succinate vs. Tolterodine - 54 seconds ago
- Prostate Cancer and drugs of ingredients of cefazolin sodium - 56 seconds ago
- Pamine and Famotidine drug interaction - 59 seconds ago
- Pepcid and Genital Herpes - a minute ago
- Probiotic vs. Magnesium - a minute ago
- Invega Sustenna and Injection Site Discoloration - a minute ago
- Vicodin Es vs. Darvocet-N 50 - 2 minutes ago
- Digoxin and Octreotide Acetate drug interaction - 2 minutes ago
- Hypokalemia and Urine Output - Decreased - 2 minutes ago